Bronwen Mayo
University of South Australia, SA, Australia
- This delegate is presenting an abstract at this event.
Bronwen is a second year PhD Student at the University of South Australia. She is completing her studies as a member of the Mucositis Research Group, under the guidance of Professor Dorothy Keefe. Her main focus is trialling interventions for chemotherapy and targeted therapy-induced intestinal damage in animal models.
Presentations this author is a contributor to:
The new selective GLP-2 receptor agonist, Elsiglutide, improves irinotecan-induced diarrhoea and mucositis in the rat. (#224)
3:00 PM
Bronwen Mayo
Poster discussion 1
Apoptosis, proliferation and inflammation are improved after treatment with the new selective GLP-2 receptor agonist, Elsiglutide, in a rat model of irinotecan-induced mucositis. (#225)
3:00 PM
Bronwen Mayo
Poster discussion 1